← Back
$TBPH All transactions

Theravance Biopharma, Inc.

A

$ Value

$0

Shares

24,258

Price

$0

Filed

May 21

Insider

Name

MITCHELL DEAN J

Title

CIK

0001199297

Roles

Director

Transaction Details

Transaction Date

2025-05-19

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

24,258

Footnotes

This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.

Filing Info

Accession No.

0001415889-25-014015

Form Type

4

Issuer CIK

0001583107

MITCHELL DEAN J's History

Date Ticker Type Value
2025-09-24 PRAX M $28K
2025-09-24 PRAX M $379K
2025-09-24 PRAX M $77K
2025-09-24 PRAX M $0
2025-09-24 PRAX M $0
2025-09-24 PRAX M $0
2025-06-26 PRAX A $0
2025-05-19 TBPH A $0
2025-05-19 TBPH A $0

Other Insiders at TBPH (90d)

Insider Bought Sold Last
Winningham Rick E
CHIEF EXECUTIVE OFFICER
2026-04-01
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
2026-04-01
Sawaf Aziz
SVP & CHIEF FINANCIAL OFFICER
2026-04-01
Grimaud Brett A.
SVP, GEN COUNSEL AND SECRETARY
2026-04-01